Skip to main content

Day: March 5, 2024

Sandoz announces nominations to the Board of Directors and leadership change

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASEMathai Mammen and Michael Rechsteiner nominated to stand for election to Sandoz Board of Directors at upcoming Annual General Meeting Remco Steenbergen appointed as Sandoz CFO and member of Executive Committee as of July 1, 2024, and consequently not standing for re-election to Board of Directors Colin Bond to retire as CFO of Sandoz on June 30, 2024Basel, March 5, 2024 – The Board of Directors of Sandoz announced today that it proposes Mathai Mammen, M.D., Ph.D., and Michael Rechsteiner for election to its Board of Directors at the company’s Annual General Meeting on April 30, 2024. At the same time, Sandoz announced today that Remco Steenbergen, currently a Sandoz Board member, will become a member of the Executive Committee and take on the...

Continue reading

Corbion sustainability performance earns 2024 EcoVadis gold medal rating

According to the most recent independent assessment from the experts at EcoVadis, Corbion’s overall sustainability performance continues to rank among the top 2% of all audited companies in its manufacturing segment. Leading global ingredient supplier Corbion has been named a 2024 EcoVadis gold medal recipient for its overall achievements in sustainability, marking its eighth year of association with EcoVadis, the leading provider of trusted business sustainability ratings, with a global network ofmore than 125,000 rated companies. The EcoVadis assessment examined Corbion’s policies, actions and results across all production facilities worldwide, scoring the company’s performance in the areas of environment, labor and human rights, ethics and sustainable procurement. “The expert, unbiased perspective EcoVadis provides...

Continue reading

Mithra initiates monetization process, receives bridge loan from existing lenders

   Mithra initiates monetization process, receives bridge loan from existing lendersMithra appoints advisors and initiates a process to monetize its assets or execute a sale of its business Mithra has entered into a new secured bridge loan facility in a committed amount of up to EUR 13.5 million, subject to milestones; with an uncommitted facility of a further EUR 5 million Bridge loan facility provides expected liquidity runway to fund the monetization process with respect to key assets through 30 April Secured lenders to certain key Mithra operating entities agree to standstill and forbear all debt service (including by extending maturity) in support of the monetization processLiege, Belgium, 05 March 2024 – 07:00 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces the initiation of a monetization...

Continue reading

Mithra announces changes to its executive management

Mithra announces changes to its executive management Liege, Belgium, 05 March 2024 – 07:00 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces the termination of the management agreement with David Horn Solomon1 as CEO and his replacement by Christophe Maréchal2 and Xavier Paoli as co-CEOs. As announced today, Mithra will commence a monetization process involving the sale of various selected assets of Mithra and/or the business as a whole (the “Monetization Process“). Concurrent therewith, the board of directors decided that a change in Mithra’s management was needed. Therefore, Mr. Solomon’s1 management agreement was terminated with immediate effect. To lead Mithra from now on, the board of directors has decided to appoint Christophe Maréchal2 and Xavier Paoli as co-CEOs pending...

Continue reading

Avance Gas Holding Ltd (AGAS): Successfully completed the sale of Venus Glory

Hamilton, Bermuda March 5, 2024 Avance Gas Holding Ltd. («Avance Gas» or «Company») (OSE: AGAS) announce today the successful delivery of the 2008-built VLGC Venus Glory at a cash consideration of $66 million less ordinary broker commission of one percent as previously announced in a press release dated 3 January 2024. The vessel completed her two-year Time Charter with IOC at end of December 2023. Subsequent to completion of this Time Charter, Venus Glory also carried out a single spot voyage at a net Time Charter Equivalent (TCE) result of $5.5 million prior to delivery of the vessel to the new owners which is reflected in the announced booking level for Q1-2024. The Company expect to record a book gain on sale and a cash release following repayment of bank financing of $27 million and $40 million respectively. Additionally, and as previously...

Continue reading

CARBIOS Active, the enzymatic solution for 100% compostable PLA, added to FDA Inventory of Food Contact Substances

CARBIOS Active integrated in compostable food trays made of PLACARBIOS Active integrated in compostable food trays made of PLACARBIOS Active, the enzymatic solution for 100% compostable PLA, added to FDA Inventory of Food Contact SubstancesPLA1 packaging integrating CARBIOS Active is 100% compostable even at ambient temperatures, supporting Food & Beverage brands in achieving their sustainability commitmentsClermont-Ferrand, France, Tuesday 5 March 2024 (06.45am CET) CARBIOS (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, announced today that CARBIOS Active, its enzymatic solution for the biodegradation of PLA, is included in the U.S. Food and Drug Administration Inventory of Effective Food Contact Substances...

Continue reading

iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029

SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict and help prevent disease, announced today the pricing of its offering of $575.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The aggregate principal amount of the offering was increased from the previously announced offering size of $450.0 million. iRhythm also granted the initial purchasers of the notes an option to purchase, within a 13-day period from, and including, the date on which the notes are first...

Continue reading

Malibu shines a light on CLINUVEL’s pioneering work in photomedicine

MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) — Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of Lady Gaga and Michael Polansky. The event, hosted by Lady Gaga and Mr. Polansky, and Sean Parker and Alexandra Parker, shone a light on the groundbreaking work of CLINUVEL, a global biopharmaceutical firm whose cutting-edge melanocortin therapies transform the lives of patients at the highest risk of photodamage and skin cancer. Mr. Parker and Mr. Polansky have supported CLINUVEL for more than 15 years, finding alignment between the Company’s pioneering approach to medicine and the boundary-pushing work of the Parker Institute for Cancer Immunotherapy which works to revolutionise healthcare. Over a family-style dinner...

Continue reading

UTime Limited Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule

NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) — UTime Limited (“UTime” or the “Company”) (Nasdaq: UTME), a mobile device manufacturing company committed to providing cost effective products and solutions to consumers globally and helping low-income individuals from established and emerging markets, today announced that on February 28, 2024, the Company received a written notification from the Nasdaq’s Listing Qualifications Department, granting the Company another 180 calendar days extension, or until August 26, 2024, to regain compliance with Nasdaq’s minimum bid price requirement. The Company can cure this deficiency if the closing bid price of its ordinary shares is $1.00 per share or higher for at least 10 consecutive business days during this second compliance period. The Company intends to regain compliance with the minimum...

Continue reading

Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios at February 29, 2024

HOUSTON, March 04, 2024 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of February 29, 2024. As of February 29, 2024, the Company’s net assets were $1.8 billion, and its net asset value per share was $10.69. As of February 29, 2024, the Company’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 642% and the Company’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 451%.STATEMENT OF ASSETS AND LIABILITIESFEBRUARY 29, 2024   // (UNAUDITED)     (in millions)Investments   $ 2,474.5  Cash...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.